<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Rural Health &amp; Human Services News by Topic: Pharmacy and prescription drugs - Rural Health Information Hub</title>
    <link>https://www.ruralhealthinfo.org/news/topics/pharmacy-and-prescription-drugs</link>
    <description>Rural Health &amp; Human Services News by Topic: Pharmacy and prescription drugs - Rural Health Information Hub</description>
    <language>en</language>
    <copyright>Copyright 2026 Rural Health Information Hub</copyright>
    <item>
      <title>CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request</title>
      <link>https://www.federalregister.gov/documents/2026/11/13/2026-23119/agency-information-collection-activities-submission-for-omb-review-comment-request</link>
      <description>Notice from the Centers for Medicare &amp; Medicaid Services (CMS) seeking comments on the following information collections: 1) Survey of Retail Prices and 2) Basic Health Program (BHP) Supporting Regulations. Comments are due by December 14, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39186</guid>
      <pubDate>Fri, 13 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request</title>
      <link>https://www.federalregister.gov/documents/2026/11/13/2026-23146/agency-information-collection-activities-submission-for-omb-review-comment-request</link>
      <description>Notice from the Centers for Medicare &amp; Medicaid Services (CMS) seeking comments on the following information collections: 1) Electronic Funds Transfer Authorization Agreement and 2) Rebate Reduction Requests under Sections 11101 and 11102 of the Inflation Reduction Act (IRA). Comments are due by December 14, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39187</guid>
      <pubDate>Fri, 13 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS: Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program</title>
      <link>https://www.federalregister.gov/documents/2026/11/09/2026-22743/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other</link>
      <description>Notice of a final rule from the Centers for Medicare &amp; Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; 3) limiting Medicare coverage of certain individuals; 4) the Ambulatory Specialty Model; 5) updates to drugs and biological products paid under Part B; 6) Medicare Shared Savings Program requirements; 7) updates to the Quality Payment Program; 8) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 9) updates to the Ambulance Fee Schedule regulations; 10) codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2026 provisions; 11) updates to Clinical Laboratory Fee Schedule regulations; and 12) updates to the Medicare Promoting Interoperability Program. These regulations are effective January 1, 2027.</description>
      <guid>https://www.ruralhealthinfo.org/news/39164</guid>
      <pubDate>Mon, 09 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program</title>
      <link>https://www.federalregister.gov/documents/2026/11/09/2026-22792/medicare-drug-price-negotiation-program-and-medicare-prescription-drug-benefit-program</link>
      <description>Notice of a final rule from the Centers for Medicare &amp; Medicaid Services (CMS) that codifies the Medicare Drug Price Negotiation Program, establishes certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and finalizes a proposed modification to the fixed combination drug policy. These regulations are effective December 5, 2026, and are applicable to the Negotiation Program with respect to initial price applicability year 2029 and to Part D Program coverage beginning January 1, 2029.</description>
      <guid>https://www.ruralhealthinfo.org/news/39173</guid>
      <pubDate>Mon, 09 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS: Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026; Correction</title>
      <link>https://www.federalregister.gov/documents/2026/11/09/2026-22807/medicare-program-implementation-of-sections-6219-6220-and-6224-of-the-consolidated-appropriations</link>
      <description>Notice from the Centers for Medicare &amp; Medicaid Services (CMS) making typographical corrections to the &lt;a href="https://www.federalregister.gov/documents/2026/10/20/2026-21420/medicare-program-implementation-of-sections-6219-6220-and-6224-of-the-consolidated-appropriations"&gt;October 20, 2026, proposed rule&lt;/a&gt;.</description>
      <guid>https://www.ruralhealthinfo.org/news/39178</guid>
      <pubDate>Mon, 09 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request</title>
      <link>https://www.federalregister.gov/documents/2026/11/05/2026-22611/agency-information-collection-activities-submission-for-omb-review-comment-request</link>
      <description>Notice from the Centers for Medicare &amp; Medicaid Services (CMS) seeking comments on the following information collections: 1) Collection Requirements for Compendia for Determination of Medically-accepted Indications for Off-label Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen; 2) Quality Bonus Payment Appeals; and 3) The In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems Survey Mode Experiment. Comments are due by December 7, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39161</guid>
      <pubDate>Thu, 05 Nov 2026 00:00:00 -0600</pubDate>
    </item>
    <item>
      <title>CMS:  Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026</title>
      <link>https://www.federalregister.gov/documents/2026/10/20/2026-21420/medicare-program-implementation-of-sections-6219-6220-and-6224-of-the-consolidated-appropriations</link>
      <description>Notice of a proposed rule that would implement the following sections of the Consolidated Appropriations Act, 2026: 1) section 6219, "Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals;" 2) section 6220, "Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act;" and 3) section 6224, "Modernizing and Ensuring Pharmacy Benefit Manager Accountability." The implementation of Section 6219 would reduce the generic drug copayment from $1 to $0 for full-benefit dual eligible individuals at or below 100% of the Federal Poverty Level, effective for plan years starting January 1, 2028. The implementation of Section 6220, the REAL Health Providers Act, would establish new provider directory accuracy and accountability requirements for Medicare Advantage (MA) organizations beginning in contract year 2028. In addition, CMS has several proposals to implement section 6224, which established requirements related to pharmacy benefit managers (PBMs) and their affiliates specific to the Medicare Part D program. Comments are due by December 15, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39103</guid>
      <pubDate>Tue, 20 Oct 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>CMS: Global Benchmark for Efficient Drug Pricing (GLOBE) Model</title>
      <link>https://www.federalregister.gov/documents/2026/10/02/2026-20281/global-benchmark-for-efficient-drug-pricing-globe-model</link>
      <description>Notice of final rule from the Centers for Medicare &amp; Medicaid Services (CMS) implementing the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biological products reduces costs for Original Medicare fee-for-service (FFS) beneficiaries and the Medicare program while preserving quality of care. This rule also summarizes and responds to comments received on the &lt;a href="https://www.federalregister.gov/documents/2025/12/23/2025-23702/global-benchmark-for-efficient-drug-pricing-globe-model"&gt;December 23, 2025, proposed rule&lt;/a&gt;, including the potential impact of this model on small rural hospitals. These regulations are effective November 30, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39047</guid>
      <pubDate>Fri, 02 Oct 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Q&amp;A: Why Rural Pharmacies Prioritize Trust Over Technology</title>
      <link>https://www.drugtopics.com/view/why-rural-pharmacies-prioritize-trust-over-technology</link>
      <description>Offers an interview with an Appalachian pharmacy educator discussing access to pharmacies for rural communities. Discusses policy, rural culture, barriers in healthcare access, trust, and rural innovation.</description>
      <guid>https://www.ruralhealthinfo.org/news/39048</guid>
      <pubDate>Wed, 30 Sep 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>CMS: Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards</title>
      <link>https://www.federalregister.gov/documents/2026/09/24/2026-19535/request-for-information-medicare-part-d-reasonable-and-relevant-pharmacy-contracting-standards</link>
      <description>Notice from the Centers for Medicare &amp; Medicaid Services (CMS) seeking public input regarding the establishment of standards for reasonable and relevant pharmacy contract terms and conditions under the Medicare prescription drug benefit as outlined by Section 6223(a) of the Consolidated Appropriations Act, 2026 (P.L. 119-75). Specifically, CMS seeks comments on pharmacy reimbursement and dispensing fees, current contract practices, trends in contract terms and conditions, and pharmacy quality and performance measures, among other things. Comments are due by November 23, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/39015</guid>
      <pubDate>Thu, 24 Sep 2026 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Pharmacies, Hospitals Expand Access to Opioid Addiction Treatment Medication, Study Shows, as Philly Experts Eye Telehealth</title>
      <link>https://whyy.org/articles/pharmacies-hospitals-opioid-addiction-medication-expansion-philadelphia-telehealth/</link>
      <description>Describes disparities in buprenorphine treatment availability in rural areas despite new data showing a national increase in the medication in pharmacies and emergency departments. Discusses challenges that continue to exist in rural Pennsylvania and highlights telehealth as a tool that could support improved access to the medication.</description>
      <guid>https://www.ruralhealthinfo.org/news/38999</guid>
      <pubDate>Mon, 21 Sep 2026 00:00:00 -0500</pubDate>
    </item>
  </channel>
</rss>
